The MADO study of the need, reasons and strategies for dose adjustment in allergen immunotherapy: patient profiles

被引：0
|
作者：
Thetis-Soulie, M. [1 ]
Hosotte, M. [2 ]
Grozelier, I [3 ]
Baillez, C. [4 ]
Scurati, S. [5 ]
Mercier, V [6 ]
机构：
[1] Private Practice, Creteil, France
[2] Gentilly Allergy Ctr, Nancy, France
[3] Private Practice, Cholet, France
[4] Private Practice, Perpignan, France
[5] Stallergenes Greer, Med Affairs, Antony, France
[6] Private Practice, Toulouse, France
来源：
ALLERGY | 2021年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
269
引用
收藏
页码：41 / 41
页数：1
相关论文
共 43 条
  • [31] Shared decision-making between physician patients in allergen immunotherapy (AIT): A Delphi consensus study for a respiratory allergic patient questionnaire
    Vidal, C.
    Rosado Ingelmo, A.
    Mur Gimeno, P.
    Mendez Brea, P.
    Alba, P.
    Alba, P.
    Alba, P.
    Alba, P.
    Alba, P.
    Jimenez, G.
    Letran, A.
    Moreno, F.
    Vega, C.
    Rodriguez, V.
    ALLERGY, 2023, 78
  • [32] Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study
    Blome, Christine
    Hadler, Meike
    Karagiannis, Efstrathios
    Kisch, Julia
    Neht, Christopher
    Kressel, Nora
    Augustin, Matthias
    ADVANCES IN THERAPY, 2020, 37 (06) : 2932 - 2945
  • [33] Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study
    Christine Blome
    Meike Hadler
    Efstrathios Karagiannis
    Julia Kisch
    Christopher Neht
    Nora Kressel
    Matthias Augustin
    Advances in Therapy, 2020, 37 : 2932 - 2945
  • [34] Allergen-specific low-dose immunotherapy in perennial allergic rhinitis: A double-blind placebo-controlled crossover study
    Radcliffe, MJ
    Lampe, FC
    Brostoff, J
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 1996, 6 (04) : 242 - 247
  • [35] Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study
    Senti, Gabriela
    von Moos, Seraina
    Tay, Fabian
    Graf, Nicole
    Sonderegger, Theodor
    Johansen, Pal
    Kuendig, Thomas M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (01) : 128 - 135
  • [36] Clinical profiles of house dust mite allergic patient initiating sublingual immunotherapy, results from the ACTIVE study in real world settings
    Migueres, M.
    Delaisi, B.
    Jeanpetit, Y.
    Ebbo, D.
    Massabie, Y-P
    de Blay, F.
    ALLERGY, 2013, 68 : 480 - 481
  • [37] FAMILY ATTITUDES AND PATIENT SOCIAL-ADJUSTMENT IN A LONGITUDINAL-STUDY OF OUTPATIENT SCHIZOPHRENICS RECEIVING LOW-DOSE NEUROLEPTICS - THE FAMILYS VIEW
    KREISMAN, D
    BLUMENTHAL, R
    BORENSTEIN, M
    WOERNER, M
    KANE, J
    RIFKIN, A
    REARDON, G
    PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES, 1988, 51 (01): : 3 - 13
  • [38] PATIENT AND CAREGIVER-REPORTED SYMPTOMS AND REASONS FOR STARTING/STOPPING RECOMBINANT FACTOR VIIA (RFVIIA) TREATMENT: OBSERVATIONS FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE)
    Valentino, L. A.
    Walsh, C. E.
    Reding, M.
    Tugal, O.
    Cooper, D. L.
    Young, G.
    VALUE IN HEALTH, 2010, 13 (03) : A213 - A213
  • [39] Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE)
    Valentino, L. A.
    Walsh, C. E.
    Reding, M. T.
    Young, G. A.
    Levendoglu-Tugal, O.
    Cooper, D. L.
    HAEMOPHILIA, 2012, 18 (04) : 554 - 560
  • [40] Patient/caregiver-reported bleed symptoms and reasons for starting/stopping treatment with recombinant factor VIIa (rFVIIa): analysis of the dosing observational study in hemophilia (DOSE)
    Valentino, L.
    Walsh, C.
    Reding, M.
    Young, G.
    Tugal, O.
    Cooper, D.
    HAEMOPHILIA, 2010, 16 : 79 - 79
12345